Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Proteine (RARRES3)

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. Zusätzlich bieten wir Ihnen Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Antikörper (69) und Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Kits (2) und viele weitere Produktgruppen zu diesem Protein an.

alle Proteine anzeigen Gen GeneID UniProt
RARRES3 5920 Q9UL19
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Proteine auf antikoerper-online.de

Showing 3 out of 4 products:

Katalog Nr. Origin Quelle Konjugat Bilder Menge Anbieter Lieferzeit Preis Details
Escherichia coli (E. coli) Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Anmelden zum Anzeigen 30 bis 35 Tage
$5,370.21
Details
Insektenzellen Human rho-1D4 tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 0.5 mg Anmelden zum Anzeigen 50 bis 55 Tage
$7,493.38
Details
Wheat germ Human GST tag 2 μg Anmelden zum Anzeigen 11 bis 12 Tage
$230.67
Details

RARRES3 Proteine nach Spezies und Herkunft

Origin Exprimiert in Konjugat
Human , ,
, ,

Weitere Proteine zu Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Interaktionspartnern

Human Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Interaktionspartner

  1. we observed frameshift mutations of RARRES3 in 11 cases of colorectal cancer

  2. Identified the tumor suppressor RARRES3 as a critical target of G9a. Epigenetic silencing of RARRES3 contributed to the tumor-promoting function of G9a

  3. this study indicated that increased expression of TIG3 in primary glioblastoma is a novel biomarker for predicting poor outcome of patients. We then hypothesize that TIG3 may function in a different pattern in glioblastoma

  4. Overexpression of TIG3 suppresses tumor growth in hepatocellular carcinoma

  5. Letter: Interleukin-22 inhibits tazarotene-induced gene 3 expression in keratinocytes via MAPK-ERK1/2 and JAK2/STAT3 signaling.

  6. findings provide a new insight into the molecular link between p53, protein acylation and Wnt/beta-catenin signaling whereby RARRES3 plays a pivotal role in modulating the acylation status of signaling proteins.

  7. the flexible main loop of H-REV107, but not that of TIG3, is critical for its NTD to modulate its CTD in inducing cell death.

  8. RARRES3 downregulation engages metastasis-initiating capabilities by facilitating adhesion of the tumor cells to the lung parenchyma.

  9. These findings argue that TIG3 is involved in the control of keratinocyte differentiation and that loss of TIG3 in transformed cells contributes to the malignant phenotype.

  10. We show that the C-terminal hydrophobic domain targets intact TIG3 to the plasma membrane, but when isolated as an independent element localizes at the mitochondria and a segment of the N-terminal hydrophilic region targets the centrosome.

  11. Low RIG1 expression is associated with testis cancer.

  12. RIG1 gene is a downstream target of p53 in cancer cell lines

  13. Data suggest that pericentrosomal localization of TIG3 is a key event that results in microtubule and microfilament redistribution and pericentrosomal organelle clustering and that leads to cancer cell apoptosis.

  14. We conclude that TG1-catalysed cross-linking, regulated by TIG3, might play an important role in the formation of neuronal tau inclusions in certain tauopathies

  15. induction of TIG3 is associated with the suppression of anchorage-independent growth in certain aerodigestive tract cancer cells

  16. TIG3 facilitates the terminal stages in keratinocyte differentiation via activation of type I transglutaminase

  17. altered RARRES3 expression may play a role in the carcinogenesis of the liver and biliary tract.

  18. identification and characterization of the functional RA response element that is responsible for the RA-mediated induction of RIG1 gene

  19. TIG3 is negatively regulated by an activated MEK-ERK signaling pathway in ovarian carcinoma.

  20. The proapoptotic and anti-RAS activities of RIG1 are primarily associated with the Golgi localization of the protein.

Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3) Protein Überblick

Protein Überblick

Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator.

Genbezeichner und Symbole assoziert mit RARRES3

  • retinoic acid receptor responder 3 (RARRES3)
  • retinoic acid receptor responder (tazarotene induced) 3 L homeolog (rarres3.L)
  • zgc:92249 (zgc:92249)
  • HRASLS4 Protein
  • HRSL4 Protein
  • MGC68773 Protein
  • PLA1/2-3 Protein
  • RARRES3 Protein
  • RIG1 Protein
  • TIG3 Protein

Bezeichner auf Proteinebene für RARRES3

HRAS-like suppressor 4 , RAR-responsive protein TIG3 , retinoic acid receptor responder protein 3 , retinoic acid-inducible gene 1 , retinoid-inducible gene 1 protein , tazarotene-induced gene 3 protein , retinoic acid receptor responder (tazarotene induced) 3

GENE ID SPEZIES
5920 Homo sapiens
398865 Xenopus laevis
436896 Danio rerio
451277 Pan troglodytes
483772 Canis lupus familiaris
Ausgewählte Anbieter für Retinoic Acid Receptor Responder (Tazarotene Induced) 3 Proteine (RARRES3)
Haben Sie etwas anderes gesucht?